丁长河, 高军, 白璐佳, 孟珺, 樊俊敏, 魏书音. 人源性丁酸梭菌的筛选及益生特性研究[J]. 河南工业大学学报自然科学版, 2024, 45(3): 69-77. DOI: 10.16433/j.1673-2383.202310120001
    引用本文: 丁长河, 高军, 白璐佳, 孟珺, 樊俊敏, 魏书音. 人源性丁酸梭菌的筛选及益生特性研究[J]. 河南工业大学学报自然科学版, 2024, 45(3): 69-77. DOI: 10.16433/j.1673-2383.202310120001
    DING Changhe, GAO Jun, BAI Lujia, MENG Jun, FAN Junmin, WEI Shuyin. Screening of Clostridium butyricum of human origin and study on its beneficial properties[J]. Journal of Henan University of Technology(Natural Science Edition), 2024, 45(3): 69-77. DOI: 10.16433/j.1673-2383.202310120001
    Citation: DING Changhe, GAO Jun, BAI Lujia, MENG Jun, FAN Junmin, WEI Shuyin. Screening of Clostridium butyricum of human origin and study on its beneficial properties[J]. Journal of Henan University of Technology(Natural Science Edition), 2024, 45(3): 69-77. DOI: 10.16433/j.1673-2383.202310120001

    人源性丁酸梭菌的筛选及益生特性研究

    Screening of Clostridium butyricum of human origin and study on its beneficial properties

    • 摘要: 为了得到人体来源的丁酸梭菌并研究其益生特性,通过选择性培养基筛选、形态学鉴定和分子生物学鉴定相结合的方法,从33位健康志愿者粪便样品中筛选出1株丁酸梭状芽孢杆菌(Clostridium butyricum B-3),以商业化菌株Clostridum butyricum MIY588作为阳性对照,通过体外模拟试验评价其模拟消化道耐受性、胆盐耐受性、抗生素敏感性、抗氧化能力、体外降血脂能力等。结果表明:Clostridium butyricum B-3对模拟消化道环境及胆盐具有较强的耐受性,模拟胃肠道存活率大于80%;对青霉素、氨苄西林、诺氟沙星、环丙氟哌酸、庆大霉素、阿米卡星具有敏感性,对复方新诺明、红霉素和头孢唑林等具有耐药性;C. butyricum B-3菌悬液(IS)的羟自由基清除率最高,约为80%;两株菌上清液(FS)的DPPH自由基清除率和还原力能力相当,均显著高于IS和无细胞提取物(CFE)(P<0.05);两株菌的IS对两种胆酸盐的结合能力均高于FS;C. butyricum B-3的FS对胰脂肪酶抑制率低于对照菌株,但IS的胰脂肪酶抑制率显著高于对照菌株(P<0.05),为44.02%;C. butyricum B-3的胆固醇清除能力为21.07%,略低于对照菌株。C. butyricum B-3具有作为优良益生菌的潜力,可应用于功能性食品的研发。

       

      Abstract: Clostridium butyricum (C. butyricum) is a probiotic. C. butyricum of human origin was obtained by a combination of selective media screening, morphological identification, and molecular biological identification. Its probiotic properties such as antioxidant capacity and lipid-lowering capacity were investigated experimentally. One strain named C. butyricum B-3 was screened from the faeces of 33 healthy volunteers. A commercial strain, C. butyricum MIY588, was introduced as a positive control. Moreover, their probiotic properties were evaluated, including simulated digestive tract tolerance, bile salt tolerance, antibiotic sensitivity, antioxidant capacity, and lipid-lowering capacity by in vitro simulation tests. The results showed that C. butyricum B-3 was highly tolerant to the simulated digestive tract environment and bile salts, with a survival rate of 94.47% in simulated artificial gastric fluid, 82.11% in simulated artificial intestinal fluid, and higher than 89% in high concentrations of bile salts. It was sensitive to penicillin, ampicillin, norfloxacin, cyclofloxacin, gentamicin, amikacin, and resistant to cotrimoxazole and erythromycin and cefazolin. The intact strains (IS) of C. butyricum B-3 had the highest hydroxyl radical scavenging rate at around 80%. The fermentation supernatants (FS) of both strains had comparable DPPH radical scavenging and reducing power capacities, which were significantly higher than those of IS and cell-free extract (CFE) (P<0.05). The binding capacity of IS for both bile salts was higher than that of FS for both strains. The inhibition of pancreatic lipase by FS for C. butyricum B-3 was lower than that of the control strain, but the inhibition of pancreatic lipase by IS was significantly higher than that of the control strain (P<0.05) at 44.02%. The cholesterol scavenging capacity of C. butyricum B-3 was 21.07%, which was slightly lower than that of the positive control strain. The above results indicate that C. butyricum B-3 has the potential to be an excellent probiotic and has great exploitation value in the research and development of functional foods.

       

    /

    返回文章
    返回